Merck & Co., Inc. is positioned strongly within the healthcare industry, providing diversified products and services across pharmaceutical and animal health segments. Its collaborations with major healthcare companies highlight its robust engagement in innovative treatment solutions. The stock appears to present a balanced risk-to-reward profile given its current fundamentals.
The fundamental rating of Merck & Co., Inc. suggests a moderate performance with specific strength in equity returns and discounted cash flow.
| Category | Score | Visualization |
|---|---|---|
| Overall | 3 | |
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 1 | |
| Price To Earnings | 1 | |
| Price To Book | 1 |
The historical scores reflect the consistency in Merck & Co., Inc.'s fundamental strengths over time, notwithstanding minor variations.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
| Historical High | 0 | 4 | 5 | 5 | 1 | 1 | 1 |
Analyst predictions suggest a positive outlook with a consensus leaning towards a higher future valuation.
| High | Low | Median | Consensus |
|---|---|---|---|
| 150 | 100 | 133 | 129.31 |
The current mood among analysts shows a tendency towards buying, with a notable preference in buy recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 25 | |
| Hold | 11 | |
| Sell | 1 | |
| Strong Sell | 0 |
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.